Compound information
- Natural Products
- ZC847325
- Molecular Formula
- C17H21N3O
- Molecular Weight
- 283.168462292 g/mol
- Structure
-
- IUPAC Name
- 4-(2-naphthylmethyl)-1,4-diazepane-1-carboxamide
- InChI
- InChI=1S/C17H21N3O/c18-17(21)20-9-3-8-19(10-11-20)13-14-6-7-15-4-1-2-5-16(15)12-14/h1-2,4-7,12H,3,8-11,13H2,(H2,18,21)
- InChI Key
- VCONNKLOLHCFNO-UHFFFAOYSA-N
- SMILES
- NC(=O)N1CCCN(Cc2ccc3ccccc3c2)CC1
- Source
- ZINC000171884011
Warheads
- Urea carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 21 | Ring Count | 3 |
Heteroatom Count | 4 | Rotatable Bond Count | 2 |
Hydrogen Bond Acceptor Count | 2 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 49.57 Å2 | LogP | 2.254 |
LogS | -2.761 | LogD | 2.011 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.15 | Pgp substrate | 0.628 |
HIA | 0.962 | F20 % | 0.883 |
F30 % | 0.313 | Caco-2 | -4.64 |
MDCK | -4.824 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.995 | PPB | 87.601 |
VD | 2.776 | Fu | 0.275 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.001 | CYP1A2 substrate | 0.773 |
CYP2A6 substrate | 0.843 | CYP2B6 substrate | 0.798 |
CYP2C19 inhibitor | 0.285 | CYP2C19 substrate | 0.798 |
CYP2C8 substrate | 0.791 | CYP2C9 inhibitor | 0.053 |
CYP2C9 substrate | 0.398 | CYP2D6 inhibitor | 0.8 |
CYP2D6 substrate | 0.998 | CYP2E1 substrate | 0.841 |
CYP3A4 inhibitor | 0.015 | CYP3A4 substrate | 0.953 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.07 | CL | 9.213 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.45 | Hepatotoxicity | 0.421 |
Mutagenicity | 0.202 | Rat Oral Acute Toxicity | 0.699 |
FDAMDD | 0.256 | Skin Sensitization | 0.793 |
Carcinogenicity | 0.233 | Eye Corrosion | 0.003 |
Eye Irritation | 0.016 | Respiratory Toxicity | 0.898 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.291 | IGC50 | 3.79 |
LC50FM | 0.949 | LC50DM | -3.138 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.496 | NR-AR-LBD | 0.21 |
NR-AhR | 0.399 | NR-Aromatase | 0.016 |
NR-ER | 0.343 | NR-ER-LBD | 0.353 |
NR-PPAR-gamma | 0.173 | SR-ARE | 0.821 |
SR-ATAD5 | 0.306 | SR-HSE | 0.191 |
SR-MMP | 0.008 | SR-p53 | 0.06 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.